Giancane, Gabriella http://orcid.org/0000-0003-2558-3559
Rosina, Silvia
Consolaro, Alessandro
Ruperto, Nicolino http://orcid.org/0000-0001-8407-7782
Article History
Accepted: 20 January 2021
First Online: 8 March 2021
Declarations
:
: No ethical approval was required.
: Not applicable.
: Not applicable.
: Gabriella Giancane has no conflicts of interest to declare.Silvia Rosina has no conflicts of interest to declare.Alessandro Consolaro reports Investigator initiated research grant from Pfizer and speaker’s bureaus from Abbvie.Nicolino Ruperto has received honoraria for consultancies or speaker bureaus (< 10.000 USD each) from the following pharmaceutical companies in the past 3 years: Ablynx, Astrazeneca-Medimmune, Bayer, Biogen, Boehringer, Bristol Myers and Squibb, Celgene, Eli-Lilly, EMD Serono, Glaxo Smith and Kline, Hoffmann-La Roche,Janssen, Merck, Novartis, Pfizer, R-Pharma, Sinergie, Sobi and UCB.The IRCCS Istituto Giannina Gaslini (IGG), where NR works as full-time public employee has received contributions (> 10.000 USD each) from the following industries in the last 3 years: BMS, Eli-Lilly, GlaxoSmithKline, F Hoffmann-La Roche, Janssen, Novartis, Pfizer, Sobi. This funding has been reinvested for the research activities of the hospital in a fully independent manner, without any commitment with third parties.
: This article does not contain any studies with human or animal subjects performed by any of the authors.